Concert: 2Q Earnings Snapshot
LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $18.7 million in its second quarter.
On a per-share basis, the Lexington, Massachusetts-based company said it had a loss of 78 cents.
The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 92 cents per share.
The biopharmaceutical company posted revenue of $49,000 in the period.
Concert shares have fallen 20% since the beginning of the year. The stock has decreased 37% in the last 12 months.